Quarterly report · Q2
3593.TEDINET S100S5FF
Period2023-04-01 → 2023-09-30
Filed2023-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥19.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥39.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥19.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥3.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.4bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥6.7bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.2bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.4bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥3.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.7bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.2bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.7bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥2.2bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥101.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥102.2bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥100.9bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥15.2bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥18.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥86.4bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥83.7bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥83.2bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥17.8bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.9bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥17.0bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.4bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.8bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥71.4 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.87 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥177.95 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥92.05 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.28 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 84.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 429
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of treasury stock fin cf | Prior1YTDDuration | -0 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | － | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -836000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -921000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -1836000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -1921000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 574000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 468000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 1543000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -1316000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 13820000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 18351000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 15363000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 17034000000 | JPY |
| Employees salaries and bonuses sga | Prior1YTDDuration | 1100000000 | JPY |
| Employees salaries and bonuses sga | CurrentYTDDuration | 1142000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 278000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 320000000 | JPY |
| Provision for directors bonuses sga | Prior1YTDDuration | 40000000 | JPY |
| Provision for directors bonuses sga | CurrentYTDDuration | 50000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 86000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 84000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-11-08 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第63期第２四半期（自 2023年７月１日 至 2023年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社ホギメディカル | |
| Company name in english cover page | FilingDateInstant | ＨＯＧＹ ＭＥＤＩＣＡＬ ＣＯ.,ＬＴＤ. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 保木 潤一 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区赤坂２丁目７番７号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)０３（６２２９）１３００（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 管理本部長 川久保 秀樹 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区赤坂２丁目７番７号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)０３（６２２９）１３００（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 管理本部長 川久保 秀樹 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02315 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 35930 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社ホギメディカル | |
| Filer name in english | FilingDateInstant | HOGY MEDICAL CO.,LTD. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |